Market Movers

UnitedHealth Group Incorporated’s Stock Price Takes a Dip, Down 6.44% to $458.14

UnitedHealth Group Incorporated (UNH)

458.14 USD -31.56 (-6.44%) Volume: 11.85M

UnitedHealth Group Incorporated’s stock price stands at 458.14 USD, experiencing a sharp drop of -6.44% in today’s trading session with a trading volume of 11.85M. The healthcare giant’s year-to-date performance also reflects a decline of -12.98%, indicating a challenging market environment.


Latest developments on UnitedHealth Group Incorporated

UnitedHealth Group (NYSE:UNH) experienced significant stock price movements today, largely contributing to the Dow’s selloff. The health insurer’s shares fell 7.1% following disappointing final Medicare Advantage rates, leading to a broader market slide. Despite an ongoing investigation into the company and a recent cyberattack on a UnitedHealth unit, Fitch maintains this will not impact credit for not-for-profit hospitals. In corporate news, UnitedHealth Group recently appointed CFO John Rex as President and announced plans for its Optum unit to acquire Steward’s Physician Group.


A look at UnitedHealth Group Incorporated Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth4
Resilience3
Momentum3
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

The long-term outlook for UnitedHealth Group looks promising, according to the Smartkarma Smart Scores. The company has received a score of 3 for Value, indicating that it is moderately priced compared to its competitors. This suggests that the company may have room for growth and potential for investors looking for a good deal.

In addition, UnitedHealth Group has received a score of 4 for both Dividend and Growth. This means that the company not only pays out a steady dividend to its shareholders, but also has a strong potential for growth in the future. This combination of stability and growth makes UnitedHealth Group an attractive option for investors.

Furthermore, the company has received a score of 3 for both Resilience and Momentum. This indicates that UnitedHealth Group has a moderate level of resilience, meaning it is able to withstand economic downturns, and a moderate level of momentum, meaning it has the potential to continue growing and performing well in the market. Overall, the Smartkarma Smart Scores suggest a positive long-term outlook for UnitedHealth Group, making it a company to watch for potential investors.

Based on the description of the company, UnitedHealth Group is a leading provider of organized health systems. They offer products and resources to employers for planning and administering employee benefit programs. With a global reach, UnitedHealth Group is well-positioned to continue its growth and success in the long-term. Its strong dividend and growth potential, along with its moderate levels of resilience and momentum, make it an attractive option for investors looking for stability and potential for future growth.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars